Literature DB >> 26819488

Incorporating Corrections for the Head-Holder and Compensation Filter when Calculating Skin Dose during Fluoroscopically-Guided Interventions.

Sarath Vijayan1, Vijay K Rana1, Stephen Rudin1, Daniel R Bednarek1.   

Abstract

The skin dose tracking system (DTS) that we developed provides a color-coded illustration of the cumulative skin dose distribution on a 3D graphic of the patient during fluoroscopic procedures for immediate feedback to the interventionist. To improve the accuracy of dose calculation, we now have incorporated two additional important corrections (1) for the holder used to immobilize the head in neuro-interventions and (2) for the built-in compensation filters used for beam equalization. Both devices have been modeled in the DTS software so that beam intensity corrections can be made. The head-holder is modeled as two concentric hemi-cylindrical surfaces such that the path length between those surfaces can be determined for rays to individual points on the skin surface. The head-holder on the imaging system we used was measured to attenuate the primary x-rays by 10 to 20% for normal incidence, and up to 40% at non-normal incidence. In addition, three compensation filters of different shape are built into the collimator apparatus and were measured to have attenuation factors ranging from 58% to 99%, depending on kVp and beam filtration. These filters can translate and rotate in the beam and their motion is tracked by the DTS using the digital signal from the imaging system. When it is determined that a ray to a given point on the skin passes through the compensation filter, the appropriate attenuation correction is applied. These corrections have been successfully incorporated in the DTS software to provide a more accurate determination of skin dose.

Entities:  

Keywords:  Compensation filter; Dose tracking; Fluoroscopic interventional procedures; Head Holder; Skin dose

Year:  2015        PMID: 26819488      PMCID: PMC4725604          DOI: 10.1117/12.2082292

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  4 in total

Review 1.  Radiochromic film dosimetry: past, present, and future.

Authors:  Slobodan Devic
Journal:  Phys Med       Date:  2010-11-02       Impact factor: 2.685

2.  Verification of the performance accuracy of a real-time skin-dose tracking system for interventional fluoroscopic procedures.

Authors:  Daniel R Bednarek; Jeffery Barbarits; Vijay K Rana; Srikanta P Nagaraja; Madhur S Josan; Stephen Rudin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-13

3.  Scatter reduction for high resolution image detectors with a region of interest attenuator.

Authors:  Amit Jain; Daniel R Bednarek; Stephen Rudin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-03-19

4.  Updates in the real-time Dose Tracking System (DTS) to improve the accuracy in calculating the radiation dose to the patients skin during fluoroscopic procedures.

Authors:  Vijay K Rana; Stephen Rudin; Daniel R Bednarek
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-06
  4 in total
  4 in total

1.  Organ and effective dose reduction for region-of-interest (ROI) CBCT and fluoroscopy.

Authors:  Zhenyu Xiong; Sarath Vijayan; Stephen Rudin; Daniel R Bednarek
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-09

2.  Monte Carlo investigation of backscatter point spread function for X-ray imaging examinations.

Authors:  Zhenyu Xiong; Sarath Vijayan; Stephen Rudin; Daniel R Bednarek
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-09

3.  Calculation of the entrance skin dose distribution for fluoroscopically guided interventions using a pencil beam backscatter model.

Authors:  Sarath Vijayan; Zhenyu Xiong; Stephen Rudin; Daniel R Bednarek
Journal:  J Med Imaging (Bellingham)       Date:  2017-06-14

4.  Skin dose mapping for non-uniform x-ray fields using a backscatter point spread function.

Authors:  Sarath Vijayan; Zhenyu Xiong; Alok Shankar; Stephen Rudin; Daniel R Bednarek
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.